1. Inhalable particulate drug delivery systems for lung cancer therapy: Nanoparticles, microparticles, nanocomposites and nanoaggregates
   Hadeer M. Abdelaziz et al, 2018, Journal of Controlled Release CrossRef
2. Pulmonary delivery of cationic liposomal hydroxycamptothecin and 5-aminolevulinic acid for chemo-sonodynamic therapy of metastatic lung cancer
   Zhimei Xiao et al, 2021, International Journal of Pharmaceutics CrossRef
3. Polymeric Nanoparticle-Based Drug/Gene Delivery for Lung Cancer
   Lipika Ray, 2019, Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer CrossRef
4. Optimization of a dry powder inhaler of ciprofloxacin-loaded polymeric nanomicelles by spray drying process
   Mahdieh Farhangi et al, 2019, Pharmaceutical Development and Technology CrossRef
5. Enhanced anti-tumor efficacy of temozolomide-loaded carboxylated poly(amido-amine) combined with photothermal/photodynamic therapy for melanoma treatment
   Jianqin Tang et al, 2018, Cancer Letters CrossRef
6. Inhalation delivery of repurposed drugs for lung cancer: Approaches, benefits and challenges
   Popat Kumbhar et al, 2022, Journal of Controlled Release CrossRef
7. Thermodynamic Solubility Profile of Temozolomide in Different Commonly Used Pharmaceutical Solvents
   Abdul Ahad et al, 2022, Molecules CrossRef
8. Addressing Unmet Medical Needs Using Targeted Drug‐Delivery Systems: Emphasis on Nanomedicine‐Based Applications
   Chandrakantsing Pardeshi et al, 2022, Targeted Drug Delivery CrossRef
9. Customizable resveratrol spray-dried micro-composites for inhalation as a promising contender for treatment of idiopathic pulmonary fibrosis
   Sara Ahmed et al, 2023, International Journal of Pharmaceutics CrossRef
10. A novel stimulus-responsive temozolomide supramolecular vesicle based on host–guest recognition
    Mingfang Ma et al, 2019, Colloid and Polymer Science CrossRef
11. La chimiothérapie inhalée – partie 1 : concept et challenges technologiques actuels
    R. Rosière et al, 2018, Revue des Maladies Respiratoires CrossRef
12. Improving chemotherapy drug delivery by nanoprecision tools
    Nehal Salahuddin et al, 2017, Nanostructures for Cancer Therapy CrossRef
13. The potential to treat lung cancer via inhalation of repurposed drugs
    Wing-Hin Lee et al, 2018, Advanced Drug Delivery Reviews CrossRef
14. “Nano-in-Micro” Structured Dry Powder Inhalers for pulmonary delivery: Advances and challenges
    Jinxue Cao et al, 2024, Journal of Drug Delivery Science and Technology CrossRef
15. Inhaled Micro/Nanoparticulate Anticancer Drug Formulations: An Emerging Targeted Drug Delivery Strategy for Lung Cancers
    Nazrul Islam et al, 2019, Current Cancer Drug Targets CrossRef
16. Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities
    Sharad Mangal et al, 2017, Acta Pharmacologica Sinica CrossRef
17. Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapy
    Rémi Rosière et al, 2016, International Journal of Pharmaceutics CrossRef
18. Constitutional mismatch repair-deficiency: current problems and emerging therapeutic strategies
    Malak Abedalthagafi, 2018, Oncotarget CrossRef
19. Inhalable dry powder prepared from folic acid-conjugated docetaxel liposomes alters pharmacodynamic and pharmacokinetic properties relevant to lung cancer chemotherapy
    Xiaojie Zhu et al, 2019, Pulmonary Pharmacology & Therapeutics CrossRef
20. Dual-Drug Containing Core-Shell Nanoparticles for Lung Cancer Therapy
    Jyothi U. Menon et al, 2017, Scientific Reports CrossRef
21. Inhalable nanomedicine for lung cancer treatment
    Shuiying Zhang et al, 2024, Smart Materials in Medicine CrossRef